Phase II trial of mitolactol in previously treated and untreated patients with advanced colorectal cancer: an Illinois Cancer Council trial

Cancer Treat Rep. 1984 Oct;68(10):1303-4.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Colonic Neoplasms / drug therapy*
  • Drug Evaluation
  • Female
  • Humans
  • Leukopenia / chemically induced
  • Male
  • Middle Aged
  • Mitolactol / adverse effects
  • Mitolactol / therapeutic use*
  • Rectal Neoplasms / drug therapy*

Substances

  • Mitolactol